Action

JAK

Alt Name

Approval Jurisdiction

2021 Japan

Approved for clinical use

Rhematoid arthritis

Brutto

CAS

944118-01-8

Commercial Vendor

Astellas Janssen

Compound Image

Peficitinib.png

Compound name

Peficitinib

InChI

InChI=1S/C18H22N4O2/c19-16(23)13-8-21-17-12(1-2-20-17)15(13)22-14-10-3-9-4-11(14)7-18(24,5-9)6-10/h1-2,8-11,14,24H,3-7H2,(H2,19,23)(H2,20,21,22)/t9?,10-,11+,14?,18?

InChI Key

DREIJXJRTLTGJC-JQCLMNFQSA-N

MW

326.40

PubChem CID

57928403

Reference

Reference 2

SMILES

C1C2CC3CC(C2)(CC1C3NC4=C5C=CNC5=NC=C4C(=O)N)O

Approved Drug List

1